| Erin R Vanness, MD | |
|
200 Scenery Dr, State College, PA 16801-7974 | |
| (814) 231-4560 | |
| (814) 231-6246 |
| Full Name | Erin R Vanness |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 25 Years |
| Location | 200 Scenery Dr, State College, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912976135 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 45630 (Wisconsin) | Secondary |
| 207N00000X | Dermatology | MD465296 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Altoona Regional Health Services, Inc. | 5395659312 | 214 |
News Archive
Helen Genova, PhD, received a $599,103 grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) for the three-year study, "Using virtual reality to improve job reentry in adults with traumatic brain injury: a randomized controlled trial." Dr. Genova, principal investigator, is assistant director of the Center for Neuropsychology and Neuroscience Research at Kessler Foundation.
TearLab Corporation today announced that it has been granted U.S. Patent No. 7,810,380, entitled "Systems and methods for collecting tear film and measuring tear film osmolarity." This patent provides the company with broad and blocking intellectual property regarding the measurement of genetic and protein biomarkers within the tear film.
A study published today in the American Journal of Public Health estimates that 1,857 people injected drugs in the last six months in Cabell County, W.Va., a rural county with a population of 94,958. This estimate is based on an innovative survey technique that public health officials can now use in their own rural communities to address the opioid epidemic.
TrovaGene, Inc., a developer of transrenal molecular diagnostics, confirmed today that it regained ownership of its worldwide rights and control over its patent estate for transrenal technology for non-invasive prenatal applications and cancer through the termination of a license agreement between TrovaGene and Sequenom, Inc.
Risk factors for stroke rise sharply in post-menopausal women in the first year after they are diagnosed with breast cancer, according to preliminary research to be presented in Honolulu at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.
› Verified 2 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Helen Genova, PhD, received a $599,103 grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) for the three-year study, "Using virtual reality to improve job reentry in adults with traumatic brain injury: a randomized controlled trial." Dr. Genova, principal investigator, is assistant director of the Center for Neuropsychology and Neuroscience Research at Kessler Foundation.
TearLab Corporation today announced that it has been granted U.S. Patent No. 7,810,380, entitled "Systems and methods for collecting tear film and measuring tear film osmolarity." This patent provides the company with broad and blocking intellectual property regarding the measurement of genetic and protein biomarkers within the tear film.
A study published today in the American Journal of Public Health estimates that 1,857 people injected drugs in the last six months in Cabell County, W.Va., a rural county with a population of 94,958. This estimate is based on an innovative survey technique that public health officials can now use in their own rural communities to address the opioid epidemic.
TrovaGene, Inc., a developer of transrenal molecular diagnostics, confirmed today that it regained ownership of its worldwide rights and control over its patent estate for transrenal technology for non-invasive prenatal applications and cancer through the termination of a license agreement between TrovaGene and Sequenom, Inc.
Risk factors for stroke rise sharply in post-menopausal women in the first year after they are diagnosed with breast cancer, according to preliminary research to be presented in Honolulu at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.
› Verified 2 days ago
| Entity Name | Upmc Altoona Regional Health Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396724217 PECOS PAC ID: 5395659312 Enrollment ID: O20040312000257 |
News Archive
Helen Genova, PhD, received a $599,103 grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) for the three-year study, "Using virtual reality to improve job reentry in adults with traumatic brain injury: a randomized controlled trial." Dr. Genova, principal investigator, is assistant director of the Center for Neuropsychology and Neuroscience Research at Kessler Foundation.
TearLab Corporation today announced that it has been granted U.S. Patent No. 7,810,380, entitled "Systems and methods for collecting tear film and measuring tear film osmolarity." This patent provides the company with broad and blocking intellectual property regarding the measurement of genetic and protein biomarkers within the tear film.
A study published today in the American Journal of Public Health estimates that 1,857 people injected drugs in the last six months in Cabell County, W.Va., a rural county with a population of 94,958. This estimate is based on an innovative survey technique that public health officials can now use in their own rural communities to address the opioid epidemic.
TrovaGene, Inc., a developer of transrenal molecular diagnostics, confirmed today that it regained ownership of its worldwide rights and control over its patent estate for transrenal technology for non-invasive prenatal applications and cancer through the termination of a license agreement between TrovaGene and Sequenom, Inc.
Risk factors for stroke rise sharply in post-menopausal women in the first year after they are diagnosed with breast cancer, according to preliminary research to be presented in Honolulu at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin R Vanness, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: () - | Erin R Vanness, MD 200 Scenery Dr, State College, PA 16801-7974 Ph: (814) 231-4560 |
News Archive
Helen Genova, PhD, received a $599,103 grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) for the three-year study, "Using virtual reality to improve job reentry in adults with traumatic brain injury: a randomized controlled trial." Dr. Genova, principal investigator, is assistant director of the Center for Neuropsychology and Neuroscience Research at Kessler Foundation.
TearLab Corporation today announced that it has been granted U.S. Patent No. 7,810,380, entitled "Systems and methods for collecting tear film and measuring tear film osmolarity." This patent provides the company with broad and blocking intellectual property regarding the measurement of genetic and protein biomarkers within the tear film.
A study published today in the American Journal of Public Health estimates that 1,857 people injected drugs in the last six months in Cabell County, W.Va., a rural county with a population of 94,958. This estimate is based on an innovative survey technique that public health officials can now use in their own rural communities to address the opioid epidemic.
TrovaGene, Inc., a developer of transrenal molecular diagnostics, confirmed today that it regained ownership of its worldwide rights and control over its patent estate for transrenal technology for non-invasive prenatal applications and cancer through the termination of a license agreement between TrovaGene and Sequenom, Inc.
Risk factors for stroke rise sharply in post-menopausal women in the first year after they are diagnosed with breast cancer, according to preliminary research to be presented in Honolulu at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.
› Verified 2 days ago
Timothy David Mckinley, Dermatology Medicare: Medicare Enrolled Practice Location: 200 Scenery Dr, State College, PA 16801 Phone: 814-231-4560 Fax: 814-231-6246 | |
Dr. Cassandra Joy Simonetta, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 32 Colonnade Way, State College, PA 16803 Phone: 814-272-4445 Fax: 814-272-4450 | |
Jerry Forrest Mikesell, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1393 N Atherton St, State College, PA 16803 Phone: 814-238-6097 Fax: 814-238-5527 | |
Dr. Loretta A Pratt, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1850 E Park Ave, Suite 312, State College, PA 16803 Phone: 814-237-6600 Fax: 814-237-5383 | |
Mary Amanda Jacobs, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 Scenery Dr., State College, PA 16801 Phone: 814-231-4560 Fax: 814-231-6246 | |
Mark Edward Kozminsky, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2505 Green Tech Dr, Suite A1, State College, PA 16803 Phone: 814-237-6600 Fax: 814-237-5383 | |
Dr. Matthew Allyn Hazey, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Scenery Dr Uppr Level, State College, PA 16801 Phone: 814-237-6600 Fax: 814-237-5383 |